Carregant...
The Impact of Donor Type and ABO Incompatibility on Transfusion Requirements after Nonmyeloablative Hematopoietic Cell Transplantation (HCT)
We retrospectively analyzed transfusion requirements within the first 100 days among allogeneic hematopoietic cell transplantation (HCT) recipients with hematological malignancies given either myeloablative (n=1353) or nonmyeloablative conditioning (n=503). We confirmed that myeloablative recipients...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2864362/ https://ncbi.nlm.nih.gov/pubmed/20067562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2009.08073.x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|